Dr Tabitha Cree
Dr Tabitha Cree
Contact
Email
show email address
Dr Tabitha Cree is a post doctoral researcher working within the muscle bioengineering lab. Tabitha has a background in cell biology, cancer biology, and cellular differentiation. in 2021, Tabitha completed her PhD at Victoria University focusing on a novel regulator of cell proliferation and differentiation using in vitro models of cellular differentiation, including cancer epithelial to mesenchymal transition, as well as myogenesis.
After completing her PhD, Tabitha moved to Sydney where she joined the lung transplant department at St Vincent's Hospital Sydney to work on their projects involving eosinophilia and chronic lung allograft dysfunction (CLAD). Tabitha's research from this project has been presented at an international transplant conference in 2023 (ISHLT23).
Upon return to Melbourne in 2023, Tabitha joined Richard Mills muscle bioengineering lab to work on modelling sarcopenia in vitro, and using young and aged 3D mini muscle to give us insight to the molecular events that cause dysfunction. These mini muscles will allow the Mills Lab to do high throughput screening on potential drug candidates and exercise regimens to improve functional outcomes. These outcomes will be translated into in vivo models in our collaboration with A/Prof Andy Philp from the Biology of Ageing Program of the Centre for Healthy Ageing at the Centenary Institute (NSW).
After completing her PhD, Tabitha moved to Sydney where she joined the lung transplant department at St Vincent's Hospital Sydney to work on their projects involving eosinophilia and chronic lung allograft dysfunction (CLAD). Tabitha's research from this project has been presented at an international transplant conference in 2023 (ISHLT23).
Upon return to Melbourne in 2023, Tabitha joined Richard Mills muscle bioengineering lab to work on modelling sarcopenia in vitro, and using young and aged 3D mini muscle to give us insight to the molecular events that cause dysfunction. These mini muscles will allow the Mills Lab to do high throughput screening on potential drug candidates and exercise regimens to improve functional outcomes. These outcomes will be translated into in vivo models in our collaboration with A/Prof Andy Philp from the Biology of Ageing Program of the Centre for Healthy Ageing at the Centenary Institute (NSW).
Dr Tabitha Cree is a post doctoral researcher working within the muscle bioengineering lab. Tabitha has a background in cell biology, cancer biology, and cellular differentiation. in 2021, Tabitha completed her PhD at Victoria University focusing on...
Dr Tabitha Cree is a post doctoral researcher working within the muscle bioengineering lab. Tabitha has a background in cell biology, cancer biology, and cellular differentiation. in 2021, Tabitha completed her PhD at Victoria University focusing on a novel regulator of cell proliferation and differentiation using in vitro models of cellular differentiation, including cancer epithelial to mesenchymal transition, as well as myogenesis.
After completing her PhD, Tabitha moved to Sydney where she joined the lung transplant department at St Vincent's Hospital Sydney to work on their projects involving eosinophilia and chronic lung allograft dysfunction (CLAD). Tabitha's research from this project has been presented at an international transplant conference in 2023 (ISHLT23).
Upon return to Melbourne in 2023, Tabitha joined Richard Mills muscle bioengineering lab to work on modelling sarcopenia in vitro, and using young and aged 3D mini muscle to give us insight to the molecular events that cause dysfunction. These mini muscles will allow the Mills Lab to do high throughput screening on potential drug candidates and exercise regimens to improve functional outcomes. These outcomes will be translated into in vivo models in our collaboration with A/Prof Andy Philp from the Biology of Ageing Program of the Centre for Healthy Ageing at the Centenary Institute (NSW).
After completing her PhD, Tabitha moved to Sydney where she joined the lung transplant department at St Vincent's Hospital Sydney to work on their projects involving eosinophilia and chronic lung allograft dysfunction (CLAD). Tabitha's research from this project has been presented at an international transplant conference in 2023 (ISHLT23).
Upon return to Melbourne in 2023, Tabitha joined Richard Mills muscle bioengineering lab to work on modelling sarcopenia in vitro, and using young and aged 3D mini muscle to give us insight to the molecular events that cause dysfunction. These mini muscles will allow the Mills Lab to do high throughput screening on potential drug candidates and exercise regimens to improve functional outcomes. These outcomes will be translated into in vivo models in our collaboration with A/Prof Andy Philp from the Biology of Ageing Program of the Centre for Healthy Ageing at the Centenary Institute (NSW).
Top Publications
- Cree, T, Gomez, TR, Timpani, CA, Rybalka, E, Price, JT, Goodman, CA. FKBP25 regulates myoblast viability and migration and is differentially expressed in in vivo models of muscle adaptation. The FEBS Journal 290(19) : 4660 -4678 2023 view publication
- Campelj, DG, Timpani, CA, Cree, T, Petersen, AC, Hayes, A, Goodman, CA, Rybalka, E. Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia.. Pharmaceuticals (Basel) 14(5) : 2021 view publication
Career information
Share //
